On May 08, 2014, KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), announced financial results for the first quarter of 2014 and provided an update on its current clinical programs and timelines. Net loss for the three months ended March 31, 2014 was $10.4 million or $0.32 per common share, as compared to $8.6 million or $0.55 per common share for the same period in 2013. KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), weekly performance is -11.47%. On last trading day company shares ended up $1.93. Analysts mean target price for the company is $7.50. KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), distance from 50-day simple moving average (SMA50) is -27.26%.
On May 12, 2014, DARA BioSciences, Inc. (NASDAQ:DARA) , announced its first quarter 2014 results. DARA reported a net loss attributable to controlling interest of ($2,658,081), or ($0.37) per share as compared to a net loss attributable to controlling interest of ($2,522,588), or ($0.55) per share for the first quarter ended March 31, 2013. As of March 31, 2014, cash and cash equivalents totaled $6,828,100. DARA Biosciences Inc (NASDAQ:DARA), fell 6.72% in last trading session and ended the day on $1.25. DARA, Gross Margin is 50.00% and its return on assets is -107.20%. DARA Biosciences Inc (NASDAQ:DARA), quarterly performance is -52.83%.
Diana Containerships Inc (NASDAQ:DCIX), reported net income of $0.3 million for the first quarter of 2014, compared to a net loss of $31.8 million for the respective period of 2013. During the first quarter of 2014, the Company incurred losses arising from the disposal of the vessel “Sardonyx”, amounting to $0.7 million, without which the net income for the first quarter of 2014 would have been $1.0 million and the earnings per share, basic and diluted, would have been $0.03 for that quarter. Diana Containerships Inc (NASDAQ:DCIX), shares moved down 12.40% in last trading session and was closed at $3.25, while trading in range of $ 3.08 – 3.64. Diana Containerships Inc (NASDAQ:DCIX), year to date (YTD) performance is -16.88%.
On 12 May 2014, Odyssey Marine Exploration Inc (NASDAQ:OMEX), reports net loss for first quarter. Odyssey reported earnings of $600,000 in the first quarter, down from $900,000 for the same period a year ago. Operations and research expenses in the first quarter of 2014 reached $7.1 million. That’s up from $5.7 million in the first quarter of 2013. Odyssey Marine Exploration Inc (NASDAQ:OMEX), ended the last trading day at $1.66. Company weekly volatility is calculated as 10.69% and price to cash ratio as 6.57. Odyssey Marine Exploration Inc (NASDAQ:OMEX), showed a negative weekly performance of -24.20%.